Welcome to our dedicated page for AQUA news (Ticker: AQUA), a resource for investors and traders seeking the latest updates and insights on AQUA stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AQUA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AQUA's position in the market.
Evoqua Water Technologies Corp. (NYSE: AQUA) will hold its Third Quarter earnings conference call on Tuesday, August 2, 2022, at 10:00 a.m. ET. The earnings results press release will be issued prior to the call. Interested parties can join via the US dial-in number (800) 459-5346 or international dial-in (203) 518-9544 using Conference ID: AQUAQ3. A replay will start at 1:00 p.m. ET on the same day and be available until 11:59 p.m. ET on August 16, 2022. Access the call and subsequent materials via the Investor Relations website.
Evoqua Water Technologies (NYSE: AQUA) has completed its acquisition of Smith Engineering, Inc., enhancing its high purity water treatment system portfolio. This strategic move aims to expand Evoqua's service footprint across North America, primarily targeting markets such as biotech, pharmaceuticals, food and beverage, healthcare, and microelectronics. With over 1,200 customers, the acquisition positions Evoqua to provide proven water solutions in key sectors. The company continues its commitment to delivering quality water treatment solutions for over 100 years.
Evoqua Water Technologies (NYSE: AQUA) announced its acquisition of Smith Engineering, enhancing its high purity water treatment capabilities and expanding its North American service footprint. Smith Engineering, based in Chaska, Minnesota, specializes in custom high purity water treatment equipment for various industries, including biotech and medical devices. With over 1,200 customers, this acquisition aims to strengthen Evoqua's market position. The transaction is expected to close in Q4 fiscal 2022, subject to standard conditions.
Evoqua Water Technologies (NYSE: AQUA) has inaugurated a new facility in Warrington, UK, serving as its global center of excellence for UV disinfection solutions. This 30,000 square-foot facility features expanded manufacturing and R&D capabilities, along with dedicated spaces for training and collaboration, enhancing Evoqua's growth potential. The facility will focus on manufacturing the environmentally friendly ATG® UV product line and will act as a project site for the Wallace & Tiernan brand's distribution in the UK market. CEO Ron Keating emphasized the company's commitment to innovation and customer support.
Evoqua Water Technologies (NYSE: AQUA) has opened a new 19,000 sq. ft. manufacturing facility in Singapore, aimed at enhancing production capabilities in response to the rising demand for innovative water treatment solutions in the Asia-Pacific (APAC) region. This facility will serve as the global manufacturing hub for Evoqua's Ionpure® Continuous Electrodeionization (CEDI) products, primarily targeting microelectronics and pharmaceutical industries. The opening is projected to create around 30 new jobs in Singapore.
Evoqua Water Technologies (NYSE:AQUA) announced robust second-quarter results for fiscal 2022, reporting revenue of $426.7 million, a 23.1% year-over-year increase. Organic revenue growth reached 10.6%, fueled by higher product and service volumes. Net income rose 45.1% to $7.4 million, with an adjusted EBITDA of $73.2 million, up 26.2%. The company raised its full-year revenue outlook to between $1.64 billion to $1.70 billion. CEO Ron Keating emphasized strong market demand and successful integration of the Mar Cor acquisition, though noted ongoing supply chain challenges.
Evoqua Water Technologies (NYSE: AQUA) announced its participation in three investor events scheduled for May and June 2022. The events include the Oppenheimer Industrial Growth Conference on May 4, featuring a fireside chat with CFO Ben Stas at 9:45 a.m. ET, the Cowen Sustainability & Energy Transition Summit on June 7 with Executive VP Snehal Desai at 2:00 p.m. ET, and the Stifel Cross Sector Insight Conference on June 8 at 1:50 p.m. ET, again with Mr. Stas. All events will be webcast, with details available on Evoqua’s Investor Relations website.
Evoqua Water Technologies Corp. (NYSE: AQUA) will hold its Second Quarter earnings conference call on May 3, 2022, at 10:00 a.m. ET. A detailed press release regarding the Company’s earnings will be issued prior to the call. Participants can join via specific dial-in numbers for US and international callers. The replay of the call will be available from 1:00 p.m. ET on May 3 until 11:59 p.m. on May 17, 2022. The live webcast and presentation slides will be accessible on Evoqua's Investor Relations website.
Evoqua Water Technologies (NYSE: AQUA) has acquired the remaining equity of San Diego-based Frontier Water Systems. This follows an initial majority investment made in October 2019. Frontier specializes in engineered solutions for the removal of selenium, nitrate, and metals from water and wastewater, enhancing Evoqua's advanced treatment capabilities. The financial terms of the deal were not disclosed. CEO Ron Keating expressed enthusiasm about uniting with Frontier for improved customer solutions.
FAQ